## **Core Concept**
Aspirin, a nonsteroidal anti-inflammatory drug (NSAID), works by irreversibly inhibiting the enzyme **cyclooxygenase (COX)**, which is crucial for the synthesis of **thromboxanes** and **prostaglandins** from arachidonic acid. This inhibition affects platelet aggregation and has various clinical implications.

## **Why the Correct Answer is Right**
The correct answer, **Bleeding Time**, is increased in patients on aspirin because aspirin's inhibition of **COX-1** in platelets leads to a decrease in the production of **thromboxane A2**, a potent stimulator of platelet aggregation. With reduced thromboxane A2, platelets are less able to aggregate, leading to an increased risk of bleeding and a prolongation of bleeding time. This effect is irreversible for the lifespan of the platelet (about 7-10 days) because aspirin acetylates and thus permanently disables the COX enzyme.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Not specified, but typically would relate to a parameter decreased or not directly affected by aspirin.
- **Option B:** Not specified, but if related to clotting factors or other coagulation tests like PT or aPTT, these are not directly affected by aspirin's mechanism of action on platelets.
- **Option C:** Not specified, but could relate to parameters that are either not directly influenced by aspirin or are decreased, such as platelet count.

## **Clinical Pearl / High-Yield Fact**
Aspirin-induced prolongation of bleeding time is a significant consideration in patients at risk of bleeding, such as those undergoing surgery. It's crucial to note that the effect of aspirin on bleeding time is not dose-dependent in terms of achieving maximal effect; low doses can effectively inhibit platelet aggregation.

## **Correct Answer:** . Bleeding Time